The screen compares growth of an indicator bacterium near a candidate isolate or its cell-free supernatant with growth in areas lacking the test material. A clear inhibition zone provides visible evidence that the isolate released an antimicrobial substance. Because this result demonstrates activity rather than molecular identity, further peptide purification or genome analysis is needed to associate the activity with a lantibiotic.
The indicator bacterium acts as a biological detector for inhibitory activity. When exposed to a colony or cell-free supernatant containing an active compound, it fails to grow locally, producing a visible clear zone. Selection of the indicator therefore determines which antimicrobial effects become detectable and provides the initial phenotype used to prioritize isolates for additional characterization.
Peptide purification follows the active material and helps connect the observed inhibition to a specific antimicrobial peptide. Genome analysis adds a genetic perspective by identifying lantibiotic biosynthetic gene clusters, which can link peptide production to its underlying pathway. Using both approaches helps relate bioactivity to peptide structure and biosynthetic potential rather than relying on inhibition alone.
Researchers first associate the zone with a producing isolate, then examine the active material and the producer's genomic information. Purification can characterize the peptide responsible for activity, while a biosynthetic gene cluster provides evidence for how the organism may produce it. This combination connects an observable competitive phenotype with molecular structure and genetic pathways.
A typical workflow begins by growing environmental isolates or culture-collection organisms. Colonies or cell-free supernatants are then tested against an indicator bacterium, and visible growth-inhibition zones are recorded. Isolates showing activity can be prioritized for peptide purification and genome analysis, allowing researchers to investigate the compound and identify a corresponding biosynthetic gene cluster.
The method is useful when researchers want to discover antimicrobial compounds from microbial diversity and connect their activity with genetic pathways. Positive isolates can support studies of microbial competition, antibiotic discovery, and peptide biosynthesis. The resulting candidates may also be relevant to food preservation, biotechnology, or therapeutic research, depending on subsequent characterization.